Syndax’s Revuforj Granted FDA Priority Review for Relapsed/Refractory Mutant NPM1 AML Published on July 9, 2025 at 12:55 am by Maham Fatima in News ...

The RRM domain–containing protein Rbp3 interacts with ribosomes and the 3’ ends of mRNAs encoding photosynthesis proteins ...

IDW’s Teenage Mutant Ninja Turtles relaunch has quickly become a force within the comics world thanks to the talented minds and skillsets of an all-star team, and this week fans can pick up the ...

Betty ___, cartoon character due to enter the public domain in 2026 Crossword Clue Q&A When was Betty ___, cartoon character due to enter the public domain in 2026 crossword clue used most recently?

A Tales of the Teenage Mutant Ninja Turtles comic book series, based on the Paramount+ streaming series, is coming this fall.

The FDA has granted priority review to an application for Revuforj for the treatment of relapsed or refractory mutant NPM1 acute myeloid leukemia.

The FDA has granted priority review to the supplemental new drug application (sNDA) of revumenib (Revuforj), an oral, first-in-class Menin inhibitor, for the treatment of relapsed or refractory (R/R) ...

Gov. Kim Reynolds laid out several objections when she vetoed a bill limiting eminent domain use. How could that guide the 2026 legislative fight?

Conclusion Teenage Mutant Ninja Turtles: Splintered Fate is a cool roguelike that may stand on its own within the legacy of the brand. While it does its homework for what the Turtles are, Splintered ...